Literature DB >> 20858842

Location, location, location-makes all the difference for hypoxia in lung tumors.

Amit Maity1, Constantinos Koumenis.   

Abstract

Hypoxia is a clinically important component of the tumor microenvironment because it adversely affects progression, metastasis, response to chemoradiation therapy, and overall patient survival. Here, we describe how different animal tumor models of lung cancer can yield surprisingly different hypoxic profiles. ©2010 AACR.

Entities:  

Mesh：

Year:  2010        PMID： 20858842      PMCID： PMC3625627          DOI： 10.1158/1078-0432.CCR-10-2004

Source DB:  PubMed          Journal:  Clin Cancer Res        ISSN： 1078-0432            Impact factor:   12.531


  9 in total

1.  Orally administered pimonidazole to label hypoxic tumor cells.

Authors:  Kevin L Bennewith; James A Raleigh; Ralph E Durand
Journal:  Cancer Res       Date:  2002-12-01       Impact factor: 12.701

Review 2.  Hypoxia: importance in tumor biology, noninvasive measurement by imaging, and value of its measurement in the management of cancer therapy.

Authors:  James L Tatum; Gary J Kelloff; Robert J Gillies; Jeffrey M Arbeit; J Martin Brown; K S Clifford Chao; J Donald Chapman; William C Eckelman; Anthony W Fyles; Amato J Giaccia; Richard P Hill; Cameron J Koch; Murali Cherukuri Krishna; Kenneth A Krohn; Jason S Lewis; Ralph P Mason; Giovanni Melillo; Anwar R Padhani; Garth Powis; Joseph G Rajendran; Richard Reba; Simon P Robinson; Gregg L Semenza; Harold M Swartz; Peter Vaupel; David Yang; Barbara Croft; John Hoffman; Guoying Liu; Helen Stone; Daniel Sullivan
Journal:  Int J Radiat Biol       Date:  2006-10       Impact factor: 2.694

3.  Orthotopic growth of human glioma cells quantitatively and qualitatively influences radiation-induced changes in gene expression.

Authors:  Kevin Camphausen; Benjamin Purow; Mary Sproull; Tamalee Scott; Tomoko Ozawa; Dennis F Deen; Philip J Tofilon
Journal:  Cancer Res       Date:  2005-11-15       Impact factor: 12.701

4.  Hypoxia in models of lung cancer: implications for targeted therapeutics.

Authors:  Edward E Graves; Marta Vilalta; Ivana K Cecic; Janine T Erler; Phuoc T Tran; Dean Felsher; Leanne Sayles; Alejandro Sweet-Cordero; Quynh-Thu Le; Amato J Giaccia
Journal:  Clin Cancer Res       Date:  2010-09-21       Impact factor: 12.531

5.  Hypoxia-specific tumor imaging with 18F-fluoroazomycin arabinoside.

Authors:  Morand Piert; Hans-Jürgen Machulla; Maria Picchio; Gerald Reischl; Sybille Ziegler; Piyush Kumar; Hans-Jürgen Wester; Roswitha Beck; Alexander J B McEwan; Leonard I Wiebe; Markus Schwaiger
Journal:  J Nucl Med       Date:  2005-01       Impact factor: 10.057

6.  Hypoxia is important in the biology and aggression of human glial brain tumors.

Authors:  Sydney M Evans; Kevin D Judy; Isolde Dunphy; W Timothy Jenkins; Wei-Ting Hwang; Peter T Nelson; Robert A Lustig; Kevin Jenkins; Deirdre P Magarelli; Stephen M Hahn; Ruth A Collins; M Sean Grady; Cameron J Koch
Journal:  Clin Cancer Res       Date:  2004-12-15       Impact factor: 12.531

Review 7.  Can we optimize chemo-radiation and surgery in locally advanced stage III non-small cell lung cancer based on evidence from randomized clinical trials? A hypothesis-generating study.

Authors:  Dirk De Ruysscher; Cary Dehing; Søren M Bentzen; Ruud Houben; André Dekker; Rinus Wanders; Jacques Borger; Monique Hochstenbag; Liesbeth Boersma; Gijs Geskes; Anne-Marie C Dingemans; Gerben Bootsma; Guido Lammering; Philippe Lambin
Journal:  Radiother Oncol       Date:  2009-07-01       Impact factor: 6.280

8.  In vivo assessment of tumor hypoxia in lung cancer with 60Cu-ATSM.

Authors:  Farrokh Dehdashti; Mark A Mintun; Jason S Lewis; Jeffrey Bradley; Ramaswamy Govindan; Richard Laforest; Michael J Welch; Barry A Siegel
Journal:  Eur J Nucl Med Mol Imaging       Date:  2003-04-12       Impact factor: 9.236

9.  The hypoxic response of tumors is dependent on their microenvironment.

Authors:  Barbara Blouw; Hanqiu Song; Tarik Tihan; Jenel Bosze; Napoleone Ferrara; Hans Peter Gerber; Randall S Johnson; Gabriele Bergers
Journal:  Cancer Cell       Date:  2003-08       Impact factor: 31.743
  9 in total
  8 in total

1.  Cigarette smoke induces the expression of Notch3, not Notch1, protein in lung adenocarcinoma.

Authors:  Zhenshun Cheng; Qiuyue Tan; Weijun Tan; L I Zhang
Journal:  Oncol Lett       Date:  2015-06-05       Impact factor: 2.967

Review 2.  Establishing the Impact of Vascular Damage on Tumor Response to High-Dose Radiation Therapy.

Authors:  Katherine D Castle; David G Kirsch
Journal:  Cancer Res       Date:  2019-08-19       Impact factor: 12.701

3.  Patterns of Vasculature in Mouse Models of Lung Cancer Are Dependent on Location.

Authors:  Marta Vilalta; Nicholas P Hughes; Rie Von Eyben; Amato J Giaccia; Edward E Graves
Journal:  Mol Imaging Biol       Date:  2017-04       Impact factor: 3.488

Review 4.  Strategies for optimizing the response of cancer and normal tissues to radiation.

Authors:  Everett J Moding; Michael B Kastan; David G Kirsch
Journal:  Nat Rev Drug Discov       Date:  2013-07       Impact factor: 84.694

5.  Generation of primary tumors with Flp recombinase in FRT-flanked p53 mice.

Authors:  Chang-Lung Lee; Everett J Moding; Xiaofang Huang; Yifan Li; Loretta Z Woodlief; Rafaela C Rodrigues; Yan Ma; David G Kirsch
Journal:  Dis Model Mech       Date:  2011-12-22       Impact factor: 5.758

6.  Dynamic FDG-PET Imaging to Differentiate Malignancies from Inflammation in Subcutaneous and In Situ Mouse Model for Non-Small Cell Lung Carcinoma (NSCLC).

Authors:  Zhen Yang; Yunlong Zan; Xiujuan Zheng; Wangxi Hai; Kewei Chen; Qiu Huang; Yuhong Xu; Jinliang Peng
Journal:  PLoS One       Date:  2015-09-30       Impact factor: 3.240

Review 7.  How to Modulate Tumor Hypoxia for Preclinical In Vivo Imaging Research.

Authors:  Sven De Bruycker; Christel Vangestel; Steven Staelens; Tim Van den Wyngaert; Sigrid Stroobants
Journal:  Contrast Media Mol Imaging       Date:  2018-10-18       Impact factor: 3.161

Review 8.  How to Improve SBRT Outcomes in NSCLC: From Pre-Clinical Modeling to Successful Clinical Translation.

Authors:  Marina Milic; Michele Mondini; Eric Deutsch
Journal:  Cancers (Basel)       Date:  2022-03-27       Impact factor: 6.639
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.